48 articles in this topic
Northwestern researchers dramatically boosted cancer vaccine effectiveness by simply repositioning one protein fragment on their nanovaccine.
Researchers found 260,000 cancer-specific RNAs that act as molecular fingerprints and can be detected through simple blood tests.
NYU study reveals microplastics in nearly all prostate tumors at concentrations 2.5 times higher than healthy tissue, suggesting potential cancer link.
Researchers discovered how to restore tumor-killing power in worn-out immune cells by switching off just two genes.
New AI tool automatically identifies cells with chromosomal defects that may lead to cancer, helping scientists study how cancer begins.
Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.
New research reveals severe respiratory infections create lasting lung inflammation that increases cancer risk, but vaccination offers protection.
Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.
New DoriVac platform uses folded DNA structures to trigger strong immune responses while being easier to manufacture and store than mRNA vaccines.
First large-scale study reveals cats and humans share key cancer mutations, potentially leading to treatments for both species.
Single injection of engineered virus kills glioblastoma cells and activates immune system, extending patient survival in clinical trial.
Researchers developed an AI system that identifies gene patterns predicting which cancers will spread, potentially transforming treatment decisions.
